Biodexa Pharmaceuticals News

Biodexa Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ionic Ventures, LLC(4.9%),Ionic Management, LLC(4.9%), etc.

Feb 14 20:48 ET

Biodexa Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CVI Investments, Inc.(0%),Heights Capital Management, Inc.(0%)

Feb 14 15:37 ET

Biodexa Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(0.94%),Steven Boyd(0.94%)

Feb 14 14:49 ET

Biodexa Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cavalry Fund I LP(9.9%),Cavalry Fund I Management LLC(9.9%), etc.

Feb 13 16:40 ET

Biodexa Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Bigger Capital Fund, LP(9.9%),Bigger Capital Fund GP, LLC(9.9%), etc.

Feb 12 16:35 ET

Biodexa Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-MERCER STREET GLOBAL OPPORTUNITY FUND, LLC(9.99%)

Jan 8 00:00 ET

Biodexa Pharmaceuticals | D: Filing D

Jan 4 00:00 ET

Biodexa Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Cavalry Fund I LP(9.9%),Cavalry Fund I Management LLC(9.9%), etc.

Dec 28, 2023 00:00 ET

Biodexa Pharmaceuticals | D: Filing D

Jun 6, 2023 19:17 ET

Midatech Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Ionic Ventures, LLC(9.99%),Brendan O’Neil(9.99%), etc.

Mar 6, 2023 06:01 ET

Midatech Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-CVI Investments, Inc.(6.2%),Heights Capital Management, Inc.(6.2%)

Feb 21, 2023 11:10 ET

Midatech Pharma | D: Filing D

Feb 17, 2023 16:49 ET

Midatech Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(8.93%),Steven Boyd(8.93%)

Feb 14, 2023 13:50 ET

Midatech Pharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Jul 10, 2020 10:48 ET

Midatech Pharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Jun 9, 2020 16:52 ET

Midatech Pharma | D: Filing D

Jun 4, 2020 16:37 ET

Midatech Pharma | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Mar 9, 2020 16:31 ET

Midatech Pharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 14, 2020 14:04 ET

Midatech Pharma | D: Filing D

Nov 7, 2019 16:48 ET

Midatech Pharma | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Nov 1, 2019 19:01 ET